Pharmaceutical

ImmunoGen and ImmunoBiochem partner for next-generation ADCs development

ImmunoGen has signed agreement with ImmunoBiochem for the development of next-generation antibody-drug conjugates (ADCs).

Jul 25, 2023 - 20:00
ImmunoGen and ImmunoBiochem partner for next-generation ADCs development
ImmunoGen has signed agreement with ImmunoBiochem for the development of next-generation antibody-drug conjugates (ADCs).
Read the original article

Tags:

Previous Article

Gilead and Cognizant expand deal to expedite digital transformation

Next Article

Private equity deals in pharmaceutical in Middle East and Africa increased in Q2...

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Black men were likely underdiagnosed with lung problems because of bias in software, study suggests

Black men were likely underdiagnosed with lung problems...

Jun 2, 2023

Travere Therapeutics drug, approved for one rare and deadly kidney disease, fails in study of another

Travere Therapeutics drug, approved for one rare and de...

May 1, 2023

STAT+: FDA approves first Alzheimer’s therapy shown to clearly slow cognitive decline

STAT+: FDA approves first Alzheimer’s therapy shown to ...

Jul 6, 2023